Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea

AIDS Research and Human Retroviruses

Volumn 13, Issue 12, 1997, Pages 995-1005

  Hunt, J C ^a   Golden, A M ^a   Lund, J K ^a   Gurtler L G ^b   Zekeng, L ^c   Obiang, J ^d   Kaptue L ^c   Hampl, H ^e   Vallari, A ^a   Devare, S G ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

^d AIDS Program   (Equatorial Guinea)

^e ABBOTT GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

AMINO ACID ANALYSIS; AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; ARTICLE; CONSENSUS SEQUENCE; ENVELOPE GENE; EQUATORIAL GUINEA; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS ENVELOPE; VIRUS ISOLATION;

EID: 0030742130     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.995     Document Type: Article

References (34)

1. DeLeys R, Vanderborght B, vanden Haesevelde M, Heyndrickx I, van Geel A, Wauters C, Bernaerts R, Saman E, Nijs P, Willems B, Taelman H, van der Groen G, Piot P, Tersmette T, Huisman JG, and van Heuverswyn H: Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J Virol 1990;64:1207-1216.
2. Haesevelde MV, Decourt J-L, De Leys RJ, Vanderborght B, van der Groen G, van Heuverswijn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68:1586-1596.
3. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP 5180) from Cameroon. J Virol 1994; 68:1581-1585.
4. Charneau P, Borman AM, Quillent C, Guetard D, Chamaret S, Cohen J, Remy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
5. Gürtler LG, Zekeng L, Simon F, Eberle J, Tsague JM, Kaptue L, Brust S, and Knapp S: Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots. J Virol Methods 1995;51:177-184.
6. Schable C, Zekeng L, Pau C-P, Hu D, Kaptue L, Gurtler L, Dondero T, Tsague J-M, Schochetman G, Jaffe H, and George JR: Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 1994;12:1333-1334.
7. Loussert-Ajaka I, Ly TD, Chaiz ML, Ingrand D, Saragosti S, Courouce AM, Brun-Vezinet F, and Simon F: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
8. Loussert-Ajaka I, Chaix ML, Korber B, Letourneur F, Gomas E, Allen E, Ly T-D, Brun-Vezinet F, Simon F, and Saragosti S: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995; 69:5640-5649.
9. Simon F, Ly TD, Baillou-Beaufils A, Schneider-Fauveau V, de Saint-Martin J, Loussert-Ajaka I, Chaix ML, Saragosti S, Courouce AM, Ingrand D, Janot C, and Brun-Vezinet F: Sensitivity of screening kits for anti-HIV-1 subtype O antibodies. AIDS 1994; 8:1628-1629.
10. Hampl H, Sawitzky D, Stöffler-Meilicke M, Groh A, Schmitt M, Eberle J, and Gürtler L: First case of HIV-1 subtype O infection in Germany. Infection 1995;23:369-370.
11. Britvan L, Gould K, Dryjanski J, Kerndt P, Mascola L, Sun R, Waterman S, Office of Blood Research and Review, Food and Drug Administration, Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention; Division of AIDS, STD, and TB Laboratory Research, National Centers for Infectious Diseases, CDC: Identification of HIV-1 group O infection - Los Angeles County, California, 1996. MMWR 1996;45:561-564.
12. Montagnier L, Clavel F, Krust B, Chamaret S, Rey F, Barre-Sinoussi F, and Chermann JC: Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology 1985;144:283-289.
13. Barin F, McLane MF, Allan JS, Lee TH, Groopman JE, and Essex M: Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science 1985;228:1094-1096.
14. Sarngadharan MG, Popovic M, Bruch L, Schupbach J, and Gallo RC: Antibodies reactive with human T-lymphotropic retroviruses (HTLV III) in the serum of patients with AIDS. Science 1984; 224:506-508.
15. Dawson GJ, Heller JS, Wood CA, Gutierrez RA, Webber JS, Hunt JC, Hojvat SA, Senn D, Devare SG, and Decker RH: Reliable detection of individuals seropositive for the human immunodeficiency virus (HIV) using Escherichia coli expessed HIV structural proteins. J Infect Dis 1988;157:149-155.
16. Gnann JW, Schwimmbeck PL, Nelson JA, Traux AB, and Oldstone MBA: Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis 1987;156:261-267.
17. Gnann JW, Nelson JA, and Oldstone MBA: Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol 1987;61:2639-2641.
18. Hunt JC, Johnson-Paepke J, Boaradway K, Gutierrez R, Hampl H, Allen R, Heynen C, Desai S, Casey J, Tribby I, Roskam G, Leung T, Sarin V, Paul D, Dawson G, Holzer T, and Devare S: Discrimination between HIV-1 and HIV-2 seropositive individuals using mouse monoclonal antibodies directed to HIV transmembrane proteins. AIDS Res Hum Retroviruses 1990;6:883-898.
19. Myers G, Korber B, Hahn BH, Jenag K-T, Mellors JW, McCutchan FE, Henderson LE, and Pavlakis GN: Human Retroviruses and AIDS 1995. Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico.
20. Gao F, Morrison SG, Robertson DL, Thornton CL, Craig S, Karlsson G, Sodroski J, Morgado M, Galvo-Castro B, von Briesen H, Beddows S, Weber J, Sharp PM, Shaw GM, Hahn B, and the WHO and NIAID Networks for HIV isolation and Characterization: Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. J Virol 1996;70:1651-1667.
21. Gürter LG, Eberle J, Lorbeer B, and Deinhardt F: Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTL VIII. J Virol Methods 1987;15:11-23.
22. Barin F, Denis F, Allan JS, M'Boup S, Kanki P, Lee TH, and Essex M: Serologic evidence for virus related to simian T-lymphotropic retrovirus III in residents of West Africa. Lancet 1985;II:1387-1389.
23. AGM). Science 1986;232:238-243.
24. Nkengasong JN, Peeters M, vanden Haesevelde M, Musi SS, willems B, Ndumbe PM, Delaporte E, Perre JL, Piot P, and van der Groen G: Antigenic evidence of the presence of the aberrant HIV-1 ANT70 virus in Cameroon and Gabon. AIDS 1993;7: 1536-1537.
25. Korber BTM, MacInnes K, Smith RF, and Myers G: Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1. J Virol 1994; 68:6730-6744.
26. Janssens W, Heyndrickx L, Fransen K, Motte J, Peeters M, Nkengasong JN, Ndumbe PM, Delaporte E, Perret JL, Atende C, Piot P, and van der Groen G: Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res Hum Retroviruses 1994;10:877-879.
27. Louwagie J, Janssens W, Mascola J, Heyndrickx L, Hegerich P, van der Groen G, McCutchan FE, and Burke DS: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
28. Cadwell RC and Joyce GF: Mutagenic PCR. PCR Methods Appl 1994;3:s136-s140.
29. Cha RS and Thilly WG: Specificity, efficiency, and fidelity of PCR. PCR Methods Appl 1993;3:s18-s29.
30. Cohen JHM, Guetard D, Philbert F, Chamaret S, Tabary T, Deleys R, and Montagnier L: Atypical HIV serological profile of novel HIV-1 variant distinct from subtype O. Lancet 1995;345:856-857.
31. Delwart EL, Shpaer EG, Louwagie J, McCutchan FE, Grez M, Rubsamen-Waigmann H, and Mullins JI: Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes. Science 1993;262:1257-1261.
32. Louwagie J, Janssens W, Mascola J, Heyndrickx L, Hegerich P, van der Groen G, McCutchan FE, and Burke DS: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
33. Delaporte E, Peeters M, Simon F, Dupont A, Schrijvers D, Kerovedan D, Josse R, Merlin M, Trebucq A, Collet M, Bedjabaga L, Honore C, Larovze B, and Brun-Vezinet F: Interpretation of antibodies reacting solely with human retroviral core proteins in western equatorial Africa. AIDS 1989;3:179-182.
34. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, Jaffe HW, Luo C-C, Kalish ML, Weniger BG, Pau C-P, Schable CA, Curran JW: The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research and prevention. JAMA 1996;275:210-216.